- Home
- JANX vs CRTO Comparison
JANX vs CRTO Comparison
Compare JANX & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- CRTO
- Stock Information
- Founded
- JANX 2017
- CRTO 2005
- Country
- JANX United States
- CRTO France
- Employees
- JANX N/A
- CRTO N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- CRTO Advertising
- Sector
- JANX Health Care
- CRTO Consumer Discretionary
- Exchange
- JANX Nasdaq
- CRTO Nasdaq
- Market Cap
- JANX 2.2B
- CRTO 2.1B
- IPO Year
- JANX 2021
- CRTO 2013
- Fundamental
- Price
- JANX $36.01
- CRTO $41.85
- Analyst Decision
- JANX Strong Buy
- CRTO Buy
- Analyst Count
- JANX 11
- CRTO 10
- Target Price
- JANX $83.09
- CRTO $54.67
- AVG Volume (30 Days)
- JANX 821.6K
- CRTO 539.3K
- Earning Date
- JANX 03-07-2025
- CRTO 02-05-2025
- Dividend Yield
- JANX N/A
- CRTO N/A
- EPS Growth
- JANX N/A
- CRTO 115.91
- EPS
- JANX N/A
- CRTO 1.90
- Revenue
- JANX $13,049,000.00
- CRTO $1,933,289,000.00
- Revenue This Year
- JANX $39.66
- CRTO N/A
- Revenue Next Year
- JANX N/A
- CRTO $8.53
- P/E Ratio
- JANX N/A
- CRTO $23.08
- Revenue Growth
- JANX 54.12
- CRTO N/A
- 52 Week Low
- JANX $14.68
- CRTO $32.00
- 52 Week High
- JANX $71.71
- CRTO $49.93
- Technical
- Relative Strength Index (RSI)
- JANX 34.78
- CRTO 50.07
- Support Level
- JANX $36.13
- CRTO $42.95
- Resistance Level
- JANX $38.13
- CRTO $47.25
- Average True Range (ATR)
- JANX 2.52
- CRTO 1.64
- MACD
- JANX 0.08
- CRTO 0.01
- Stochastic Oscillator
- JANX 5.71
- CRTO 49.56
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.